Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

• Anaïs Schavgoulidze,
• Aurore Perrot,
• Titouan Cazaubiel,
• Xavier Leleu,
• Lydia Montes,
• Caroline Jacquet,
• Karim Belhadj,
• Sabine Brechignac,
• Laurent Frenzel,
• Thomas Chalopin,
• Philippe Rey,
• Jean-Marc Schiano de Collela,
• Mamoun Dib,
• Denis Caillot,
• Margaret Macro,
• Jean Fontan,
• Laure Buisson,
• Luka Pavageau,
• Murielle Roussel,
• Salomon Manier,
• Mohamad Mohty,
• Ludovic Martinet,
• Hervé Avet-Loiseau,
• Jill Corre

Affiliations

Anaïs Schavgoulidze

Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole

Aurore Perrot

Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS)

Titouan Cazaubiel

Hematology Department, University Hospital

Xavier Leleu

Hematology Department, University Hospital

Lydia Montes

Hematology Department, University Hospital

Caroline Jacquet

Hematology Department, University Hospital

Karim Belhadj

Hematology Department, University Hospital

Sabine Brechignac

Hematology Department, University Hospital

Laurent Frenzel

Hematology Department, Necker University Hospital

Thomas Chalopin

Hematology Department, University Hospital

Philippe Rey

Hematology Department, Centre Léon Bérard

Jean-Marc Schiano de Collela

Hematology Department, Institut Paoli Calmettes

Mamoun Dib

Hematology Department, University Hospital

Denis Caillot

Hematology Department, Institut de Cancérologie de Bourgogne

Margaret Macro

Hematology Department, University Hospital

Jean Fontan

Hematology Department, University Hospital

Laure Buisson

Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole

Luka Pavageau

Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole

Murielle Roussel

Hematology Department, University Hospital

Salomon Manier

Hematology Department, University Hospital

Mohamad Mohty

Hematology Department, Saint-Antoine University Hospital

Ludovic Martinet

Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS)

Hervé Avet-Loiseau

Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole

Jill Corre

Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole